Title: Full Text of SR0273
Official Title: 
Number of Sections: 1
Source: versions - Introduced
Media Type: text/html

================================================================================

Section 1:
Full Text of SR0273 ILGA.GOV SR0273 - 104th General Assembly SR0273LRB104 13378 LAW 25703 r1SENATE RESOLUTION 2    WHEREAS, Approximately 1 in 7 American adults have chronic 3kidney disease, and the third leading cause of chronic kidney 4disease is glomerulonephritis, often caused by rare kidney 5diseases such as focal segmental glomerulosclerosis (FSGS); 6and 7    WHEREAS, FSGS is a condition referring to scarring in the 8kidneys, often leading to a difficult journey that can, in 9many cases, result in kidney failure, requiring dialysis, 10transplants, cycles of remissions and relapse, and even 11recurrence; and 12    WHEREAS, Of patients with FSGS, 50% of them require 13dialysis or a kidney transplant within 5 to 10 years of 14diagnosis; and 15    WHEREAS, FSGS is a severe disease because it often 16progresses rapidly to kidney failure, and even for patients 17who receive a kidney transplant, it can recur in their 18transplanted kidney up to 50% of the time; and 19    WHEREAS, While FSGS can be diagnosed at any age, it is most 20commonly diagnosed in adults rather than in children and most 21prevalent in adults over 45 years of age; and   SR0273- 2 -LRB104 13378 LAW 25703 r1    WHEREAS, FSGS is a burden on our healthcare system, with a 22019 study estimating that the disease costs Medicaid, 3Medicare, and private health insurance approximately $2 4billion annually in direct medical costs, not including 5indirect and quality of life costs; and 6    WHEREAS, According to data from the National Registry of 7Rare Kidney Diseases (RaDaR), rare kidney diseases like FSGS 8comprise only 5% to 10% of chronic kidney disease patients but 9account for approximately 30% of kidney failure; and 10    WHEREAS, Many patients face delays in being diagnosed with 11FSGS, due both to the difficulty of the rare disease 12diagnostic odyssey, averaging 5 to 7 years, and challenges in 13accessing nephrology care that specialize in rare kidney 14diseases due to the current shortage in the United States; and 15    WHEREAS, FSGS disproportionately impacts minority 16populations, including African Americans, often occurring at a 17rate 4 to 5 times higher than white Americans; and 18    WHEREAS, Due to certain variants of the APOL1 gene that 19significantly increase the risk of developing FSGS and other 20kidney diseases and the fact that these high-risk variants are 21found almost exclusively in individuals of African ancestry,   SR0273- 3 -LRB104 13378 LAW 25703 r1the condition contributes to the disproportionate burden of 2kidney disease in Black communities; and 3    WHEREAS, FSGS is a significant burden not only to the 4health and lives of patients and their families but also 5because the condition incurs great challenges for the 6healthcare system and healthcare financing in Illinois; and 7    WHEREAS, There is new hope for patients with FSGS, as 8clinical trials are underway for products that may delay 9progression of the condition and the onset of kidney disease, 10including the potential for FDA-approved therapies in the near 11future, and significant progress is being made by scientists, 12regulators, patient groups, and the healthcare industry to 13validate proteinuria as an indicator of improvement in 14patients; and 15    WHEREAS, Patients, families, advocacy organizations like 16NephCure, healthcare providers, the healthcare industry, and 17researchers are working tirelessly to raise awareness, promote 18early detection, and develop new innovative therapies for 19FSGS; and 20    WHEREAS, FSGS Awareness Day is designated to raise 21awareness of FSGS, to provide support and inspiration to 22patients and families struggling with the disease, and to   SR0273- 4 -LRB104 13378 LAW 25703 r1promote the efforts needed for better diagnosis and access to 2future treatments that can transform the course of the 3condition; therefore, be it 4    RESOLVED, BY THE SENATE OF THE ONE HUNDRED FOURTH GENERAL 5ASSEMBLY OF THE STATE OF ILLINOIS, that we declare June 10, 62025 as FSGS Awareness Day in Illinois to bring attention to 7the focal segmental glomerulosclerosis (FSGS) disease.


================================================================================

Raw Text:
Full Text of SR0273 ILGA.GOV SR0273 - 104th General Assembly SR0273LRB104 13378 LAW 25703 r1SENATE RESOLUTION 2    WHEREAS, Approximately 1 in 7 American adults have chronic 3kidney disease, and the third leading cause of chronic kidney 4disease is glomerulonephritis, often caused by rare kidney 5diseases such as focal segmental glomerulosclerosis (FSGS); 6and 7    WHEREAS, FSGS is a condition referring to scarring in the 8kidneys, often leading to a difficult journey that can, in 9many cases, result in kidney failure, requiring dialysis, 10transplants, cycles of remissions and relapse, and even 11recurrence; and 12    WHEREAS, Of patients with FSGS, 50% of them require 13dialysis or a kidney transplant within 5 to 10 years of 14diagnosis; and 15    WHEREAS, FSGS is a severe disease because it often 16progresses rapidly to kidney failure, and even for patients 17who receive a kidney transplant, it can recur in their 18transplanted kidney up to 50% of the time; and 19    WHEREAS, While FSGS can be diagnosed at any age, it is most 20commonly diagnosed in adults rather than in children and most 21prevalent in adults over 45 years of age; and   SR0273- 2 -LRB104 13378 LAW 25703 r1    WHEREAS, FSGS is a burden on our healthcare system, with a 22019 study estimating that the disease costs Medicaid, 3Medicare, and private health insurance approximately $2 4billion annually in direct medical costs, not including 5indirect and quality of life costs; and 6    WHEREAS, According to data from the National Registry of 7Rare Kidney Diseases (RaDaR), rare kidney diseases like FSGS 8comprise only 5% to 10% of chronic kidney disease patients but 9account for approximately 30% of kidney failure; and 10    WHEREAS, Many patients face delays in being diagnosed with 11FSGS, due both to the difficulty of the rare disease 12diagnostic odyssey, averaging 5 to 7 years, and challenges in 13accessing nephrology care that specialize in rare kidney 14diseases due to the current shortage in the United States; and 15    WHEREAS, FSGS disproportionately impacts minority 16populations, including African Americans, often occurring at a 17rate 4 to 5 times higher than white Americans; and 18    WHEREAS, Due to certain variants of the APOL1 gene that 19significantly increase the risk of developing FSGS and other 20kidney diseases and the fact that these high-risk variants are 21found almost exclusively in individuals of African ancestry,   SR0273- 3 -LRB104 13378 LAW 25703 r1the condition contributes to the disproportionate burden of 2kidney disease in Black communities; and 3    WHEREAS, FSGS is a significant burden not only to the 4health and lives of patients and their families but also 5because the condition incurs great challenges for the 6healthcare system and healthcare financing in Illinois; and 7    WHEREAS, There is new hope for patients with FSGS, as 8clinical trials are underway for products that may delay 9progression of the condition and the onset of kidney disease, 10including the potential for FDA-approved therapies in the near 11future, and significant progress is being made by scientists, 12regulators, patient groups, and the healthcare industry to 13validate proteinuria as an indicator of improvement in 14patients; and 15    WHEREAS, Patients, families, advocacy organizations like 16NephCure, healthcare providers, the healthcare industry, and 17researchers are working tirelessly to raise awareness, promote 18early detection, and develop new innovative therapies for 19FSGS; and 20    WHEREAS, FSGS Awareness Day is designated to raise 21awareness of FSGS, to provide support and inspiration to 22patients and families struggling with the disease, and to   SR0273- 4 -LRB104 13378 LAW 25703 r1promote the efforts needed for better diagnosis and access to 2future treatments that can transform the course of the 3condition; therefore, be it 4    RESOLVED, BY THE SENATE OF THE ONE HUNDRED FOURTH GENERAL 5ASSEMBLY OF THE STATE OF ILLINOIS, that we declare June 10, 62025 as FSGS Awareness Day in Illinois to bring attention to 7the focal segmental glomerulosclerosis (FSGS) disease.